Nanomol Technologies is both a Drug Delivery and a GMP certified Contract Analysis partner for pharmaceutical and biotech industries.

Our DELOS nanoformulation technology enables the development of  value-added medicines with enhanced efficacy, selectivity and reduced side-effects.

We provide value to companies who require appropriate characterization of critical quality attributes such as particle size, morphology and structural properties of both drug substance and drug products.

Neurotechnology company that turns brain signals into actionable data,  developing EEG hardware, biosignal processing tools, and neuroscience services that help pharma and biotech partners measure what's happening in the brain, objectively and at scale

RidNova is a biopharmaceutical company dedicated to addressing health challenges and driving innovation in pharmaceuticals, biosimilars, and biologics, to improve patient outcomes. We specialise in formulation development, formulation consulting, analytical and commercial manufacturing, leveraging state-of-the-art technologies and extensive industry expertise. We offer comprehensive product and dossier development and formulation, regulatory & CMC consultancy, advisory services in complex formulation, biosimilars, biologicals, 505 b (2)/hybrid, differentiated, innovative, value-added formulations to Pharma, CDMO, small biotech/startups for formulation, as well as guidance on regulatory strategy. RidNova also provides services in IP, regulatory submissions, post-launch activities and strategic publication planning to support the successful introduction and positioning of pharmaceutical assets in the market.

CCiTUB (Centres Científics i Tecnològics de la Universitat de Barcelona) is one of the largest mid-sized scientific and technical infrastructures in Spain, located at the Campus Diagonal of the University of Barcelona — the leading biotechnology hub in southern Europe.

With highly qualified technical staff and the widest variety of instrumental technologies in the country, CCiTUB offers specialised services to companies in the HealthTech sector with international quality standards, including ISO 9001:2015 certification.

Our key capabilities include:

• Biomolecular Analysis: advanced proteomics, metabolomics, and small molecule ADME/PK studies
• Pharmaceutical Characterisation: ultra-high-field NMR (1.0 GHz, unique in Spain) for biologics, antibodies, and nucleic acid fragments
• Cell Analysis: multiparametric flow cytometry, immunophenotyping, and cell sorting for advanced therapies
• Mass Spectrometry: hybrid Orbitrap IQ-X and QTRAP 7500 for metabolite identification, quality control, and biodistribution studies
• Imaging: MALDI-Imaging, cryo-FIBSEM, and correlative microscopy for neurodegenerative disease research

CCiTUB serves pharma, biotech, diagnostics, medical devices, cosmetics, and nutraceutical sectors, providing immediate access to cutting-edge technologies without capital investment, backed by a network of over 100 health sector organisations and 2,700 professionals at the Barcelona Science Park.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

About our Pharma Services

Thermo Fisher Scientific provides industry-leading pharma services for drug development, clinical trial logistics, and commercial manufacturing through our Patheon™ brand. We partner with customers in the pharmaceutical, biotech, and life sciences industries as their trusted CDMO to deliver medicine to patients faster. We believe that doing this successfully not only requires science, technology, and world-class expertise, but also requires a strategic partnership—bonded by key elements such as trust, communication, and collaboration. We embed these elements into every operation, interaction, and step in the drug development journey. https://www.patheon.com/us/en/home.html

Werfen is a growing, family-owned, and innovative company founded in 1966 in Barcelona, Spain. We operate directly in nearly 30 countries and in more than 100 territories through distributors, with headquarters and Technology Centers located in Europe and the United States. The Immunoassay Technology Center in Barcelona has consolidated experience in the research, development, and manufacturing of IVD immunoassays and biomaterials.

Innovation is one of Werfen’s fundamental pillars, and we innovate at all levels, from diagnostic targets, biomaterials and reagents, protein production processes and assay technologies. We strive to strengthen our immunoassay know-how and technological capabilities with the ultimate goal of increasing efficiency and robustness, reducing time-to-market, and streamlining operations.